Johnson & Johnson stock rises Wednesday, still underperforms market

This post was originally published on this site

© Terrence Horan


Load Error

Shares of Johnson & Johnson inched 0.62% higher to $169.49 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.82% to 4,358.69 and the Dow Jones Industrial Average rising 0.83% to 34,798.00. This was the stock’s second consecutive day of gains. Johnson & Johnson closed $4.16 below its 52-week high ($173.65), which the company reached on January 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. rose 0.69% to $386.50, Merck & Co. Inc. rose 0.29% to $76.39, and Pfizer Inc. fell 0.07% to $41.02. Trading volume (7.5 M) eclipsed its 50-day average volume of 6.5 M.

Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading